Denali Therapeutics Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): -305
EBIT TTM (mln): -505
index 0 1 2 3 4 5 6 7 8 9
Rok finansowy 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 129 27 336 49 108 331 0
Przychód Δ r/r 0.0% 0.0% 0.0% inf% -79.3% 1158.2% -85.5% 122.9% 204.7% -100.0%
Marża brutto 0.0% 0.0% 0.0% 100.0% -624.9% 36.7% 88.5% 93.5% 94.9% 0.0%
EBIT (mln) -17 -87 -90 -46 -213 63 -296 -341 -197 -487
EBIT Δ r/r 0.0% 424.2% 3.1% -48.6% 359.7% -129.4% -571.6% 15.2% -42.3% 147.8%
EBIT (%) 0.0% 0.0% 0.0% -35.9% -799.1% 18.7% -607.8% -314.2% -59.5% 0.0%
Koszty finansowe (mln) 0 0 2 0 15 0 0 15 0 0
EBITDA (mln) -17 -86 -90 -46 -213 63 -296 -330 -180 -487
EBITDA(%) 0.0% 0.0% 0.0% -35.9% -799.1% 18.7% -607.8% -304.6% -54.4% 0.0%
Podatek (mln) 0 0 -3 10 -0 1 -1 0 0 -0
Zysk Netto (mln) -17 -87 -88 -36 -198 71 -291 -326 -145 -423
Zysk netto Δ r/r 0.0% 416.2% 1.8% -58.9% 445.3% -136.0% -508.5% 12.2% -55.5% 191.1%
Zysk netto (%) 0.0% 0.0% 0.0% -28.1% -740.7% 21.2% -597.2% -300.6% -43.9% 0.0%
EPS -5.58 -13.49 -5.89 -0.39 -2.07 0.65 -2.39 -2.6 -1.06 -2.57
EPS (rozwodnione) -5.58 -13.49 -5.89 -0.39 -2.07 0.63 -2.39 -2.6 -1.06 -2.57
Ilośc akcji (mln) 3 6 15 93 96 109 122 126 137 164
Ważona ilośc akcji (mln) 3 6 15 93 96 113 122 126 137 164
Waluta USD USD USD USD USD USD USD USD USD USD